BACE1 and early-onset autosomal dominant Alzheimer disease: The elevated expression of miR-124 in Alzheimer’s disease (AD) was shown to benefit the neurite outgrowth, mitochondria activation, small Aβ oligomer reduction, and beta-site amyloid precursor protein cleaving enzyme 1 (BACE1) in experimental models and patients [9,10,62].